Recombinant Human CXCL7 (NAP-2) (carrier-free)
Recombinant Human CXCL7 (NAP-2) (carrier-free)
586602 10 µg $170.00 Qty:
586604 25 µg $295.00 Qty:

Product Details

Source: Human CXCL7, amino acids Ala59-Asp128 (Accession# NM_002704.3) was expressed in E. coli.
Molecular Mass: The 70 amino acid recombinant protein has a predicted molecular mass of approximately 7.6 kD. The DTT-reduced and non-reduced protein migrate at approximately 11 and 13 kD by SDS-PAGE respectively. The N-terminal amino acid is Ala.
Formulation: 0.22 µm filtered protein solution is in PBS.
Endotoxin Level: Less than 0.01 ng per µg cytokine as determined by the LAL method.
Concentration: 10 and 25 µg sizes are bottled at 100 µg/mL.
Storage & Handling: Unopened vial can be stored between 2°C and 8°C for three months, at -20°C for six months, or at -70°C for one year. For maximum results, quick spin vial prior to opening. Stock solutions should be prepared at no less than 10 µg/mL in sterile buffer (PBS, HPBS, DPBS, and EBSS) containing carrier protein such as 1% BSA or HSA. After dilution, the cytokine can be stored between 2°C and 8°C for one month or from -20°C to -70°C for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity: Bioactivity was measured by its property to chemoattract human neutrophils in a dose dependent manner.

BA - Quality tested

Enter Lot#:   
Recombinant Human CXCL7 (NAP-2) (carrier-free)  Image 1
Neutrophils chemoattracted by human CXCL7.


CXCL7 is an ERL+ chemokine that is secreted by activated platelets, neutrophils, lymphocytes, and macrophages as a precursor.  Pro-platelet basic protein or leukocyte derived grow factor (PPBP/LDGF) (a protein of ~14 kD) is modified by post-transcriptional cleavage to give rise to connective tissue activating peptide (CTAP-III), CXCL7, β-thromboglobulin (β-TG), and two variants of thrombocidin (TC-1 and TC-2). CTAP-III is activated by enzymatic proteolysis performed by cell surface-bound cathepsin G (CathG), a chymotryptic serine protease found in primary neutrophil granules. In this way, neutrophils are the mayor cells that convert CTAP-III into CXCL7. In addition, monocytes and mast cells can proteolytically modify CTAP-III to produce CXCL7. In fact, CathG has been detected in mast cells in addition to chymase, another chymotryptic enzyme. Further C-terminal truncations, that eliminate the last four and seven amino acids in CXCL7, generate two additional natural isoforms; these variants are more potent neutrophils activators.

High levels of CTAP-III have been detected in plasma of patients with lung cancer. In fact, it has been suggested as a biomarker for early lung cancer detection. An increase in positive immunostained cells has been detected in the bronchial submucosa of patients with stable severe chronic obstructive pulmonary disease. Also, studies with premalignant breast cancer cells transfected with CXCL7 showed that these cells became as invasive as malignant breast cancer cells. In addition, CXCL7 induces stimulation of the lymphangiogenic factors VEGF-C and VEGF-D in human breast cancer cells, suggesting an important role for CXCL7 in tumor invasion.

Other Names: Neutrophil activating protein 2 (NAP2)
Distribution: Platelets, neutrophils, lymphocytes, macrophages, endothelial cells
Function: CXCL7 stimulates chemotaxis and degranulation in neutrophils, induces transendothelial migration and neutrophil adhesion to activated endothelial cells, and has angiogenic activity. LPS induces the precursor in PBMCs.
Ligand Receptor: CXCR2
Interaction: Neutrophils, keratinocytes

1. Iida N, et al. 1996. FASEB J. 10:1336.
2. Schenk BI, et al. 2002. J. Immunol. 169:2602.
3. El-Gedaily A, et al. 2004. J. Leukoc. Biol. 75:495.
4. Schiemann F, et al. 2006. Blood 107:2234.

GeneID: 5473
Latest Publications: View the latest CXCL7 articles on
UniProt: View information about CXCL7 on
Keywords: Recombinant Human CXCL7 (NAP-2) (carrier-free), Recombinant, CXCL7 recombinant protein, recombinant CXCL7 protein, Neutrophil activating protein 2 (NAP2), Bioassay (Recombinants), Immunology, Antibodies

Product Reviews

  Title Rating Date
- There are currently no reviews for this product. Be the first to review this product to qualify for a $100 Amazon gift card drawing. -
See more reviews using the Reviews Library

Product FAQs

How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
Use formula Specific activity (Units/mg) = 10e6/ ED50 (ng/mL)
For a complete list of FAQs on all our products, visit our FAQ page.
Related Products


Related Pathways

Chemokine Receptor Biology

Related Categories

Cytokines & Chemokines > Human Cytokine & Chemokine Research > Recombinant Proteins > CXCL7 (NAP-2)
Cytokines & Chemokines > Recombinant Proteins > Human > CXCL7 (NAP-2)
Cell Biology > Signaling/Signaling Intermediates > CXCL7 (NAP-2)

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

Version: 1 Revision Date: 2013-02-20
Copyright © 2014 BioLegend, Inc. All rights reserved.